Antiseptics And Disinfectants Market Size, Share & Trends Analysis Report By Type, By Product, By End Use (Hospitals, Clinics), By Sales Channel (FMCG, B2B), By Region, And Segment Forecasts, 2021 - 2028

Report Overview 

The global antiseptics and disinfectants market size was valued at USD 23.7 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 20.8% from 2021 to 2028. An increase in the prevalence of diseases such as cholera, typhoid, food poisoning, hepatitis A, and dengue, primarily due to lack of home cleanliness, is one of the major factors expected to drive the market. For instance, as per a report published by ECDC in 2019, around three and six cases of dengue fever were reported in Spain and France, respectively, in 2018, which required risk assessment for transmission of dengue fever in Europe.

Such diseases are mainly caused by viruses, bacteria, and germs, which thrive in unhealthy home environments and unhygienic toilets, latrines, and kitchens. The application of antiseptic and disinfectant solutions is, therefore, an essential requirement to maintain home cleanliness. Such solutions prevent the growth of harmful bacteria and viruses, reducing the chance of acquiring these diseases. Hence, an increase in awareness about home cleanliness is anticipated to propel the market for antiseptics and disinfectants over the forecast period.

Gastrointestinal (GI) endoscopy allows doctors to view the inner lining of the digestive tract. The endoscope can enable the diagnosis and treatment of several GI diseases. A GI endoscopy can be performed either in inpatient or outpatient settings. However, it can lead to several complications if the endoscopes are not properly reprocessed.

Endoscopes need to be reprocessed appropriately as per infection-control guidelines to lower the risk of transferring environmental or patient-borne microorganisms between patients. In such cases, the application of proper antiseptics and disinfectant solutions is essential to prevent transmission of infections. Moreover, increasing demand for endoscopy is expected to increase the risk of getting HAIs. For instance, as per BMJ Publishing Group Ltd. and the British Society of Gastroenterology in 2018, the demand for gastrointestinal endoscopy has grown immensely for bowel cancer screening in symptomatic patients. Overall demand has nearly doubled in many U.K. centers over the past 5 years. Therefore, increasing use of endoscope reprocesses and surgical units is expected to propel the market for antiseptics and disinfectants over the forecast period.

Growing number of surgeries globally is also a key factor expected to drive the market growth over the forecast period. For instance, as per the Mölnlycke Health Care AB, 70.00 million surgical procedures are performed every year in Europe. Similarly, according to the Healthcare Cost and Utilization Project (HCUP), in 2018, more than 9,942,000 surgeries were performed in the U.S. within ambulatory care settings. In the case of surgeries, the use of antiseptics and disinfectant products is one of the essential requirements in hospitals, clinics, and ambulatory surgery centers. Therefore, such instances are expected to drive the market.

Type Insights

The quaternary ammonium compounds segment dominated the market for antiseptics and disinfectants and held the largest revenue share of 31.3% in 2020. The growth is expected to witness considerable growth over the forecast period. Quaternary ammonium compounds are widely used as surface disinfectants in hospitals and laboratories. These compounds aid in controlling the spread of healthcare-associated infections in hospitals and clinics. In addition, it is also used for disinfecting medical equipment that comes into direct contact with skin. The rising incidence of hospital-acquired infections across the globe is likely to positively impact the segment growth. For instance, as per WHO, of every 100 hospitalized patients in a given time, 7 out of 100 hospitalized patients in developed countries and 10 out of 100 patients in developing countries acquire at least one healthcare-associated infection each year.

The enzyme segment is anticipated to witness the fastest growth rate over the forecast period. Enzyme-based disinfectants and antiseptics are generally used for odor control, generally caused due to chemical reactions. It is also used for cleaning enzyme-based or catalyst-based products and is widely used in research laboratories. It is used in hospitals and clinics for cleaning testing kits. An increasing number of research laboratories due to increasing expenditure on R&D across the globe is expected to boost the demand for these products. For instance, as per World Bank, globally, the R&D expenditure increased to 2.27% in 2015 from 2.15% in 2014, which is expected to boost the number of research laboratories owing to which segment is anticipated to grow over the forecast period.

Product Insights

The medical device disinfectants segment dominated the market for antiseptics and disinfectants and held the largest revenue share of 45.6% in 2020. The segment is expected to witness considerable growth over the forecast period. Medical device disinfectants are generally used for reprocessing of surgical units and endoscopes. Glutaraldehyde, phenol/phenate, hydrogen peroxide, and peracetic acid are some of the disinfectants used for reprocessing/disinfection of medical devices. Proper reprocessing of medical devices and endoscopes are essential as they transmit the infection from one patient to another due to direct contact with skin. An increasing number of surgical procedures across the globe may be considered to be one of the major reasons for driving the segment over the forecast period.

The enzymatic cleaners segment is anticipated to witness the fastest growth rate over the forecast period. Enzymatic cleaners are generally used in preventing odor and are most effective on bacterial surfaces. It is popularly used in hospitals and clinics for disinfecting testing kits and surgical equipment. Increasing cases of hospital-acquired infections and the number of surgical procedures are major factors drivers of the segment. Enzymatic cleaners contain non-pathogenic useful bacteria that are effective in displacing disease-causing bacteria without causing any adverse effects. Sometimes, the residue of certain antiseptics and disinfectants may pose certain harmful effects on humans. In such cases, enzymatic cleaners are used. Hence, the segment is anticipated to grow over the forecast period.

Sales Channel Insights

The B2B segment dominated the market for antiseptics and disinfectants and held the largest revenue share of 65.2% in 2020. In the B2B sales channel, companies directly sell their products to businesses and not to consumers. B2B sales channels usually have longer sales cycles and higher-order values. B2B sales channel is expected to witness a low growth rate during the forecast period owing to entry barriers in the B2B business, which includes lack of investment to develop technologically advanced products and challenges pertaining to coordinating with various vendors. Enzymatic cleaners, medical device disinfectants, and surface disinfectants are major antiseptics and disinfectants marketed under the B2B sales channel. Hospitals, clinics, healthcare providers, and suppliers are major end-users of the B2B sales channel.

The FMCG distribution channel comprises three major entities: agents, facilitators, and merchants. Agents generally generate sales by promoting the products of the company. Agents can be a member of the company or an independent individual. Facilitators are generally involved in the transportation of manufactured goods from one place to another. Warehouse owners, logistic services, and independent types are included under the facilitator’s category. Wholesalers and retailers are generally categorized under the merchant’s category. Consumers generally purchase FMCG products directly from retailers and wholesalers. Hand sanitizers, antiseptic topical creams, antiseptic washes, and antiseptics wipes are categorized under the FMCG product line. 3M, Lifebuoy, Dettol, and Purell are some of the notable brands of hand sanitizers. Nufree Finipil Pro Elec Antiseptic Cream, Tea Tree Therapy Antiseptic Cream, and Neosporin are some of the notable antiseptics topical cream brands marketed as FMCG products.

End-use Insights

The hospitals segment dominated the market for antiseptics and disinfectants and accounted for the largest revenue share of 46.0% in 2020. The increasing incidence of hospital-acquired infections across the globe is one of the major reasons for segment growth over the forecast period. For instance, as per CDC, every day around 1 out of 31 hospital patients acquire hospital-acquired infections. Usage of proper antiseptics and disinfectants is essential as it helps in preventing transmission of infections. Furthermore, increasing healthcare expenditure in developed and developing countries might increase the number of hospitals owing to which demand for antiseptics and disinfectants is also expected to increase. For instance, as per Eurostat, Germany, France, and Sweden had the highest healthcare expenditure (around 11.0%) in GDP in 2016. Thus, such factors are expected to propel the segment growth over the forecast period.

Increasing number of hospital and surgical procedures are major contributors to the segment growth over the forecast period. Maintaining proper hygiene and sanitation is necessary to maintain a healthy environment in the clinic. Furthermore, increasing cases of hospital-acquired infections may also surge the demand for antiseptics and disinfectants. Therefore, the segment is expected to grow over the forecast period.

Regional Insights

North America dominated the antiseptics and disinfectants market and accounted for the largest revenue share of 34.4% in 2020. The region is expected to witness a considerable growth rate of 20.8% over the forecast period. Increasing number of surgeries being performed in North America and the rising number of workers in the healthcare sector are among the factors expected to drive the demand for antiseptics and disinfectants in North America. Antiseptic and disinfectant solutions are essential for surgical procedures and in the field of research as they reduce the risk of contamination and transmission of infections from one patient to another. In addition, increasing cases of hospital-acquired infections may boost the demand for such solutions as doctors are increasingly recommending the usage of disinfectant solutions. Hence, these factors are expected to propel the growth of the market over the forecast period.

Increasing incidence of healthcare-associated infections, food poisoning, cholera, and typhoid fever is a major factor driving the market over the forecast period. In addition, rising awareness about home cleanliness among people is likely to positively impact the market growth. Furthermore, major players are also making efforts to enter untapped markets in the Asia Pacific region, thereby expanding the market scope.

Key Companies & Market Share Insights

Key players are involved in adopting strategies such as mergers and acquisitions, partnerships, and launching new products to strengthen their foothold in the market. Key players are entering into mergers and acquisitions to increase their market share and customer base across the globe. For instance, in June 2018, Johnson & Johnson received a binding offer from Fortive Corporation to acquire its Advanced Sterilization Products business—a part of Ethicon, Inc. Some of the prominent players in the antiseptics and disinfectants market include:

• 3M

• Reckitt Benckiser

• STERIS plc

• Kimberly-Clark Corporation

• Bio-Cide International

• Cardinal Health

• BD

• Johnson & Johnson

Antiseptics And disinfectants Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global antiseptics and disinfectants market report on the basis of type, product, sales channel, end-use, and region:

• Type Outlook (Revenue, USD Million, 2016 - 2028)

  • Quaternary Ammonium Compounds

  • Chlorine Compounds

  • Alcohols & Aldehyde Products

  • Enzyme

  • Others

• Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Enzymatic Cleaners

  • Medical Device Disinfectants

  • Surface Disinfectants

• Sales Channel Outlook (Revenue, USD Million, 2016 - 2028)

  • B2B

  • FMCG

• End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Hospitals

  • Clinics

  • Others

• Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

  • Asia Pacific

    • Japan

    • China

  • Latin America

    • Brazil

    • Mexico

  • Middle East & Africa

    • South Africa

    • Saudi Arabia